INVEMED CATALYST FUND

invemed-catalyst-fund-logo

Invemed Catalyst Fund, L.P. specializes in buyouts and minority stakes in small-cap public companies. It also sponsors corporate orphans and start-ups. The fund focuses its investments in retail, medical technology, and technology companies.

#Financial #More

INVEMED CATALYST FUND

Founded:
1999-01-01

Status:
Active


Investments List

Date Company Article Money raised
2009-10-01 Micell Technologies Invemed Catalyst Fund investment in Series B - Micell Technologies 15 M USD
2008-02-26 Proficiency Invemed Catalyst Fund investment in Venture Round - Proficiency 4.25 M USD
2007-07-12 Micell Technologies Invemed Catalyst Fund investment in Series A - Micell Technologies 7 M USD
2004-08-05 Kalypsys Invemed Catalyst Fund investment in Series B - Kalypsys 29 M USD
2003-10-01 Reliant Pharmaceuticals Invemed Catalyst Fund investment in Series D - Reliant Pharmaceuticals 115 M USD
2002-07-18 Micell Technologies Invemed Catalyst Fund investment in Venture Round - Micell Technologies 1000 K USD
2000-05-09 GoCo-op Invemed Catalyst Fund investment in Venture Round - GoCo-op 21 M USD
2000-03-16 GoCo-op Invemed Catalyst Fund investment in Venture Round - GoCo-op 6 M USD
1999-12-06 GoCo-op Invemed Catalyst Fund investment in Venture Round - GoCo-op 5 M USD

More informations about "Invemed Catalyst Fund"

Invemed Catalyst Fund - Crunchbase Investor Profile & Investments

Invemed Catalyst Fund, L.P. specializes in buyouts and minority stakes in small-cap public companies. It also sponsors corporate orphans and start-ups. The fund focuses its …See details»

Invemed Catalyst Fund: Performance - PitchBook

Mar 15, 2004 Invemed Catalyst Fund's latest investment was on 29-Jul-2009 in Micell Technologies, a company within the Drug Delivery industry. Data Transparency. Meet our data …See details»

Invemed Catalyst Fund - Investments, Portfolio & Company Exits

Oct 1, 2009 Invemed Catalyst Fund, a New York-based private equity firm, specializes in buyouts and minority stakes in small-cap public companies. Search Crunchbase. ... Which …See details»

corporate.wwe.com

Catalyst GenPar, as the general partner of the Fund, has the sole power to vote and dispose of the 64 shares of Common Stock owned by the Fund. Each of Gladwyne GenPar and Invemed, …See details»

corporate.wwe.com

1 name of reporting person invemed catalyst fund, l.p. ï¿»  2 check the appropriate box if a member of a group (a) o (b) x ï¿»  3 sec use only ï¿»  4 source of funds oo ï¿»  5 check …See details»

GLADWYNE SECURITIES, LLC

Gladwyne catalyst management, l.p. is under common control with the firm. applicant is under common control with gladwyne catalyst management, l.p. which is managing member of …See details»

Series B - Kalypsys - 2004-08-05 - Crunchbase Funding Round …

Aug 5, 2004 Organization Name . Kalypsys . Announced Date Aug 5, 2004; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . $29M. Lead Investors. Edit …See details»

GoCo-op Receives $21 Million In New Financing - Totals $32 …

May 7, 2000 GoCo-op received its latest round of funding from a group of investors led by Invemed Catalyst Fund and Safeguard Scientifics. ... deployment strategy that meets the …See details»

Invemed Catalyst Fund - CB Insights

Invemed Catalyst Fund operates as an investment fund. Use the CB Insights Platform to explore Invemed Catalyst Fund's full profile.See details»

Invemed Catalyst Fund Venture Capital Profile | VentureDeal

About VentureDeal. Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and …See details»

INVEMED CATALYST FUND LP Top 13F Holdings

Detailed Profile of INVEMED CATALYST FUND LP portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more. Research. Pricing Other. WhaleIndex. Help. …See details»

GoCo-op Secures $23 Million in New Equity Financing; Signs Five …

Jul 11, 2001 This latest funding round was led by an existing investor, the Invemed Catalyst Fund. Additionally, GoCo-op executed a new five-year contract with Avendra under which …See details»

Invemed Catalyst Fund Lp Insider Profile - TipRanks

Invemed Catalyst Fund Lp See Remarks, Ten Percent Owner at World Wrestling, is currently unranked, see this insider's latest transactions. ... My Experts Top Analysts Top Financial …See details»

Vincent K. McMahon and Invemed Catalyst Fund LP - Findlaw

All notices and other communications provided for or permitted hereunder shall be made in writing by hand delivery, telecopier, any courier guaranteeing overnight delivery or first class …See details»

Micell Technologies - Funding, Financials, Valuation & Investors

Invemed Catalyst Fund and St. Jude Medical are the most recent investors. Micell Technologies has a post-money valuation in the range of $50M to $100M as of Sep 23, 2009 , according to …See details»

Activist 13D/13G Filings - INVEMED CATALYST FUND LP

INVEMED CATALYST FUND LP sec form 13D/13G filings, stock buying and selling. ... Hedge Fund Lists; Top 100 Hedge Funds; Top 100 Most Widely Held Stocks; Stock Screener. ...See details»

Catalyst Fund Lpinvemed Cat... Net Worth (2024) - wallmine

Jun 16, 2019 wwe, a publicly traded company (nyse: wwe), is an integrated media organization and recognized leader in global entertainment. the company consists of a portfolio of …See details»

WORLD WRESTLING ENTERTAINMENT, INC. - Fintel

WORLD WRESTLING ENTERTAINMENTINC - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities …See details»

Registration Rights Agreement - Invemed Catalyst Fund LP and …

Registration Rights Agreement - Invemed Catalyst Fund LP and World Wrestling Federation Entertainment Inc.: Learn more about this contract and other key contractual terms and issues …See details»

Innovation Funding | Nova Scotia Health Innovation Hub

The Innovation Catalyst Fund provides financial support to clinical researchers whose ideas have the potential to transform into globally applicable solutions that improve the lives of patients. …See details»